GP Stock Snapshot
Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
03
Price$0.56
P/E-0.7
EPS$-1.57
Revenue$16M
ROE19158.9%
52W Range$1–$3
GP Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits1
Ex-date
Split
Type
Sept. 8, 2025
1-for-10
Reverse
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$16M2018-03-31 → 2026-03-31
EPS$-1.572020-03-31 → 2026-03-31
Free Cash Flow$-6M2020-03-31 → 2026-03-31
Net margin-33.4%2020-03-31 → 2026-03-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
GP
5Y avg
Peer Median
Verdict
P/E
-0.75Y avg ≈-34.7
≈-34.7
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
GP
5Y avg
Peer Median
Verdict
Gross Margin
56.2%5Y avg ≈27.7%
≈27.7%
·
·
Operating Margin
-24.4%5Y avg ≈-47.7%
≈-47.7%
·
·
EBITDA Margin
-24.4%5Y avg ≈-47.7%
≈-47.7%
·
·
Pretax Margin
-35.9%
·
·
·
Net Profit Margin
-33.4%5Y avg ≈-51.3%
≈-51.3%
·
·
ROA
-16.7%5Y avg ≈-27.7%
≈-27.7%
·
·
ROE
19158.9%5Y avg ≈4743.6%
≈4743.6%
·
·
ROIC
-240.2%
·
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
GP
5Y avg
Peer Median
Verdict
Current Ratio
1.55Y avg ≈2.3
≈2.3
·
·
Quick Ratio
0.05Y avg ≈0.2
≈0.2
·
·
Interest Coverage
-1.55Y avg ≈-12.6
≈-12.6
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
GP
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-1.575Y avg ≈$-3.40
≈$-3.40
·
·
Revenue / Share
$4.695Y avg ≈$2.65
≈$2.65
·
·
Cash Flow / Share
$-1.775Y avg ≈$-0.81
≈$-0.81
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
GP
5Y avg
Peer Median
Verdict
Asset Turnover
0.55Y avg ≈0.6
≈0.6
·
·
Inventory Turnover
0.35Y avg ≈0.7
≈0.7
·
·
Receivables Turnover
37.55Y avg ≈13.5
≈13.5
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement15
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Revenue
$16M
$39M
$40M
$17M
$13M
$14M
$6M
Cost of Revenue
$7M
$34M
$32M
$13M
$10M
$10M
$4M
Gross Profit
$9M
$5M
$7M
$4M
$4M
$4M
$2M
R&D Expense
$701.4K
$2M
$2M
$1M
$939.9K
$973.1K
$437.2K
Operating Income
$-4M
$-18M
$-15M
$-14M
$-8M
$-5M
$-4M
Interest Expense
$3M
$2M
$2M
$515.7K
$2M
$2M
$1M
Interest Income
$3.6K
$7.1K
$270.4K
$217.9K
$209.9K
$68.4K
$0
Pretax Income
$-6M
$-18M
·
·
·
$-5M
$-5M
Income Tax
$-406.0K
$0
$0
$0
$0
$0
$0
Net Income
$-5M
$-18M
$-15M
$-15M
$-8M
$-5M
$-5M
EPS (Basic)
$-1.57
$-7.35
$-0.64
$-0.69
$-0.43
·
·
EPS (Diluted)
$-1.57
$-7.35
$-0.64
$-0.69
$-0.43
$-0.34
·
Shares (Basic)
3,494,860
2,495,096
23,522,755
21,877,488
18,116,129
15,207,446
13,356,665
Shares (Diluted)
3,494,860
2,495,096
23,522,755
21,877,488
18,116,129
·
·
EBITDA
$-4M
$-18M
$-15M
$-14M
$-8M
$-5M
·
Balance Sheet12
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Cash & Equivalents
$328.1K
$1M
$600.4K
$884.8K
$15M
$299.7K
$198.9K
Receivables
$331.8K
$3M
$10M
$3M
$4M
$943.8K
$1M
Inventory
$24M
$32M
$42M
$32M
$12M
$7M
$5M
Current Assets
$25M
$37M
$54M
$43M
$33M
$8M
$7M
PP&E (Net)
$718.6K
$3M
$3M
$3M
$2M
$2M
$2M
Goodwill
·
·
$250.8K
·
·
·
·
Total Assets
$31M
$45M
$64M
$50M
$40M
$13M
$12M
Accounts Payable
$3M
·
·
·
·
·
·
Current Liabilities
$17M
$21M
$27M
$12M
$2M
$7M
$7M
Total Liabilities
$29M
$34M
$36M
$15M
$3M
$14M
$12M
Retained Earnings
$-103M
$-79M
$-61M
$-46M
$-32M
$-24M
$-19M
Stockholders' Equity
$2M
$12M
$28M
$34M
$36M
$-1M
$-85.6K
Cash Flow6
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Operating Cash Flow
$-6M
$-1M
$-15M
$-20M
$-16M
$-5M
$-6M
CapEx
$0
$361.5K
$356.0K
$536.1K
$352.7K
$161.9K
$120.0K
Investing Cash Flow
$11.9K
$-761.5K
$303.2K
$-536.1K
$-352.7K
$-161.9K
$179.6K
Financing Cash Flow
$6M
$2M
$8M
$13M
$32M
$6M
$5M
Free Cash Flow
$-6M
$-1M
$-15M
$-21M
$-17M
$-5M
·
Levered FCF
$-9M
·
·
·
·
$-7M
·
Profitability8
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Gross Margin
56.2%
13.6%
18.3%
22.5%
30.1%
30.0%
·
Operating Margin
-24.4%
-45.6%
-37.3%
-83.6%
-65.6%
-36.5%
·
Net Margin
-33.4%
-46.7%
-37.9%
-87.1%
-65.9%
-38.1%
·
Pretax Margin
-35.9%
·
·
·
·
-38.1%
·
EBITDA Margin
-24.4%
-45.6%
-37.3%
-83.6%
-65.6%
-36.5%
·
ROA
-16.7%
-33.7%
-26.6%
-33.6%
-29.7%
-41.0%
·
ROE
19158.9%
-93.5%
-48.5%
-42.6%
-44.8%
816.4%
·
ROIC
-240.2%
·
·
·
·
418.9%
·
Liquidity & Solvency3
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Current Ratio
1.5
1.7
2.0
3.7
15.4
1.1
·
Quick Ratio
0.0
0.2
0.4
0.3
9.2
0.2
·
Interest Coverage
-1.5
-11.5
-9.5
-27.9
-4.9
-2.3
·
Efficiency3
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Asset Turnover
0.5
0.7
0.7
0.4
0.4
1.1
·
Inventory Turnover
0.3
0.9
0.9
0.6
0.9
1.6
·
Receivables Turnover
37.5
5.9
6.0
4.7
4.4
11.5
·
Per Share3
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Revenue / Share
$4.69
$1.57
$1.69
·
·
·
·
Cash Flow / Share
$-1.77
$-0.05
$-0.63
·
·
·
·
EPS (TTM)
$-1.57
$-7.35
$-0.64
$-0.69
$-0.43
$-0.34
·
Valuation (TTM)4
Metric
Trend
2026
2024
2023
2022
2021
2020
2019
Revenue TTM
$16M
$39M
$40M
$17M
$13M
$14M
·
Net Income TTM
$-5M
$-18M
$-15M
$-15M
$-8M
$-5M
·
P/E
-0.7
-2.7
-36.1
-99.3
-578.4
·
·
Earnings Yield
-151.0%
-37.3%
-2.8%
-1.0%
-0.17%
·
·
Per Share1
Metric
Trend
Q4 2026
Q4 2025
Q4 2021
Q4 2020
EPS (TTM)
$-1.57
$-6.77
$-0.43
$-0.34
Valuation (TTM)4
Metric
Trend
Q4 2026
Q4 2025
Q4 2021
Q4 2020
Revenue TTM
$16M
$20M
$13M
$14M
Net Income TTM
$-5M
$-19M
$-8M
$-5M
P/E
-0.7
-0.7
-578.4
·
Earnings Yield
-151.0%
-138.2%
-0.17%
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2026-03-31
2025-03-31
2024-03-31
2023-03-31
2022-03-31
Revenue
$16M
$20M
$39M
$40M
$17M
Gross Margin %
56.2%
·
13.6%
18.3%
22.5%
Operating Margin %
-24.4%
·
-45.6%
-37.3%
-83.6%
Net Income
$-5M
$-19M
$-18M
$-15M
$-15M
Diluted EPS
$-1.57
$-6.77
$-7.35
$-0.64
$-0.69
Metric
2026-03-31
2025-03-31
2024-03-31
2023-03-31
2022-03-31
Current Ratio
1.5
·
1.7
2.0
3.7
Quick Ratio
0.0
·
0.2
0.4
0.3
Metric
2026-03-31
2025-03-31
2024-03-31
2023-03-31
2022-03-31
Free Cash Flow
$-6M
·
$-1M
$-15M
$-21M
Institutional owners (13F)
20 filers
· $135K total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders20
Value held$135K
New positions5
Exited positions5
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
5 (+1 vs prior Q)
5 (+3 vs prior Q)
2 (-5 vs prior Q)
3 (+2 vs prior Q)
+2K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
1 insider
· 1 officers · 1 directors